Local and systemic innate immune response to secondary human peritonitis

Critical Care

Volumn 17, Issue 5, 2013, Pages

  Riché, Florence ^a   Gayat, Etienne ^a,b   Collet, Corinne ^a,b   Matéo, Joaquim ^a   Laisné, Marie Josèphe ^a   Launay, Jean Marie ^a,b   Valleur, Patrice ^a,b   Payen, Didier ^a,b   Cholley, Bernard P ^b,c  

^a HÔPITAL LARIBOISIÈRE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CYTOKINE; GAMMA INTERFERON; GENTAMICIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; ORNIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANAEROBE; ANTIBIOTIC THERAPY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENTEROCOCCUS; FEMALE; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERITONEAL FLUID; PERITONITIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEPTIC SHOCK; SURVIVOR; BLOOD; COHORT ANALYSIS; FOLLOW UP; IMMUNOLOGY; MIDDLE AGED; PROSPECTIVE STUDY;

AGED; COHORT STUDIES; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, INNATE; MALE; MIDDLE AGED; PERITONITIS; PROSPECTIVE STUDIES;

EID: 84883711788     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12895     Document Type: Article

References (34)

1. Caille V, Chiche J, Nciri N, Berton C, Gibot S, Boval B, Payen D, Mira J, Mebazaa A. Histocompatibility leucocyte antigen-D related expression is specifically altered and predicts mortality in septic shock but not in other causes of shock. Shock 2004, 22:521-526.
2. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997, 3:678-681.
3. Lukaszewicz A, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, Payen D. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med 2009, 37:2746-2752.
4. Turrel-Davin F, Venet F, Monnin C, Barbalat V, Cerrato E, Pachot A, Lepape A, Alberti-Segui C, Monneret G. mRNA-based approach to monitor recombinant gamma-interferon restoration of LPS-induced endotoxin tolerance. Crit Care 2011, 15:R252.
5. Tsukada K, Katoh H, Shiojima M, Suzuki T, Takenoshita S, Nagamachi Y. Concentrations of cytokines in peritoneal fluid after abdominal surgery. Eur J Surg 1993, 159:475-479.
6. Holzheimer RG, Schein M, Wittmann DH. Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis. Arch Surg 1995, 130:1314-1319.
7. Patel RT, Deen KI, Youngs D, Warwick J, Keighley MR. Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg 1994, 81:1306-1308.
8. Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M. Cytokine serum level during severe sepsis in human. Il6 as a marker of severity. Ann Surg 1992, 215:356-362.
9. Paugam-Burtz C, Dupont H, Marmuse JP, Chosidow D, Malek L, Desmonts JM, Mantz J. Daily organ-system failure for diagnosis of persistent intra-abdominal sepsis after postoperative peritonitis. Intensive Care Med 2002, 28:594-598.
10. Montravers P, Dupont H, Gauzit R, Veber B, Auboyer C, Blin P, Hennequin C, Martin C. Candida as a risk factor for mortality in peritonitis. Crit Care Med 2006, 34:646-652.
11. Roehrborn A, Thomas L, Potreck O, Ebener C, Ohmann C, Goretzki PE, Roher HD. The microbiology of postoperative peritonitis. Clin Infect Dis 2001, 33:1513-1519.
12. Riche FC, Dray X, Laisne MJ, Mateo J, Raskine L, Sanson-Le Pors MJ, Payen D, Valleur P, Cholley BP. Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis. Crit Care 2009, 13:R99.
13. Onderdonk A, Weinstein W, Sullivan N, Bartlett J, Gobach S. Experimental intraabdominal abscesses in rats: quantitative bacteriology of infected animals. Infect Immun 1974, 10:1256-1259.
14. Onderdonk A, Bartlett J, Louie T, Sullivan-Seiger N, Gorbach S. Microbial synergy in experimental intra-abdominal abscess. Infect Immun 1976, 13:22-26.
15. Cavaillon J, Adib-Conquy M. Comparmentalized activation of immune cells during sepsis and organ dysfunction in "Mechanisms of sepsis-induced organ dysfunction and recovery". Update in Intensive Care Medicine 2007, 161-182. Springer-Verlag Berlin Heidelberg Germany, Vincent J.L.
16. Schein RM, Wittmann DH, Holzheimer R, Condon RE. Hypothesis: compartmentalization of cytokines in intraabdominal infection. Surgery 1996, 119:694-700.
17. Riche FC, Cholley BP, Panis YH, Laisne MJ, Briard CG, Graulet AM, Gueris JL, Valleur PD. Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis. Crit Care Med 2000, 28:433-437.
18. Hamilton G, Hofbauer S, Hamilton B. Endotoxin, TNF-alpha, interleukin-6 and parameters of the cellular immune system in patients with intraabdominal sepsis. Scand J Infect Dis 1992, 24:361-368.
19. Brede K, Kern H, Morciniec P, Beller S, Kox W, Spies C. The value of immune modulating parameters in predicting the progression from peritonitis to septic shock. Shock 2001, 2:95-100.
20. Osuchowski M, Welch K, Siddiqui J, Remick D. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 2006, 177:1967-1974.
21. Andaluz-Ojeda D, Bobillo F, Iglesias V, Almansa R, Rico L, Gandia F, Resino S, Tamayo E, de Lejarazu RO, Bermejo-Martin JF, Tamayo E, Fernandez A, Almansa R, Carrasco E, Heredia M, Lajo C, Goncalves L, Gomez-Herreras JI, de Lejarazu RO, Bermejo-Martin JF. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Cytokine 2012, 57:332-336.
22. Novotny AR, Reim D, Assfalg V, Altmayr F, Friess HM, Emmanuel K, Holzmann B. Mixed antagonist response and sepsis severity-dependent dysbalance of pro- and anti-inflammatory responses at the onset of postoperative sepsis. Biomarkers in SIRS and sepsis: quo vadis?. Immunobiology 2012, 217:616-621.
23. Ono S, Ueno C, Aosasa S, Tsujimoto H, Seki S, Mochizuki H. Severe sepsis induces deficient interferon-gamma and interleukin-12 production, but interleukin-12 therapy improves survival in peritonitis. Am J Surg 2001, 182:491-497.
24. Zantl N, Uebe A, Neumann B, Wagner H, Siewert J, Holzmann B, Heidecke C, Pfeffer K. Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun 1998, 66:2300-2309.
25. Kohler J, Heumann D, Garotta G, LeRoy D, Bailat S, Barras C, Baumgartner J, Glauser M. IFN-gamma involvement in the severity of gram-negative infections in mice. J Immunol 1993, 151:916-921.
26. Yin K, Gribbin E, Wang H. Interferon-gamma inhibition attenuates lethality after cecal ligation and puncture in rats: implication of high mobility group box-1. Shock 2005, 24:396-401.
27. Van der Poll T, Marchant A, Buurman WA, Berman L, Keogh CV, Lazarus DD, Nguyen L, Goldman M, Moldawer LL, Lowry SF. Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 1995, 155:5397-5401.
28. Munford R, Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosupressive. Am J Respir Crit Care Med 2001, 163:316-321.
29. Fry D. The generic response. Crit Care Med 2008, 36:1369-1370.
30. Tang BM, McLean AS, Dawes IW, Huang SJ, Cowley MJ, Lin RC. Gene-expression profiling of gram-positive and gram-negative sepsis in critically ill patients. Crit Care Med 2008, 36:1125-1128.
31. McConnell K, McDunn J, Clark A, Dunne W, Dixon D, Turnbull I, DiPasco P, Osberghaus B, Sherman B, Martin JW, Walter MJ, Cobb J, Buchman T, Hotchkiss R, Coopersmith C. Streptococcus pneumoniae and Pseudomonas aeruginosa pneumonia induce distinct host responses. Crit Care Med 2010, 38:223-241.
32. Gogos C, Kotsaki A, Pelekanou A, Giannikopoulos G, Vaki I, Maravitsa P, Adamis S, Alexiou Z, Andrianopoulos G, Antonopoulou A, Athanassia S, Baziaka F, Charalambous A, Christodoulou S, Dimopoulou I, Floros I, Giannitsioti E, Gkanas P, Ioakeimidou A, Kanellakopoulou K, Karabela N, Karagianni V, Katsarolis I, Kontopithari G, Kopterides P, Koutelidakis I, Koutoukas P, Kranidioti H, Lignos M, Louis K, et al. Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit Care 2010, 14:R96.
33. Montravers P, Andremont A, Massias L, Carbon C. Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis. J Infect Dis 1994, 169:821-830.
34. Montravers P, Mohler J, Saint Julien L, Carbon C. Evidence of the proinflammatory role of enterococcus faecalis in polymicrobial peritonitis in rats. Infect Immun 1997, 65:144-149.